5 Geographic Atrophy Clinical Trials in Kansas City, KS (2026)

Q: How do I join a clinical trial in Kansas City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you.

Recruiting Geographic Atrophy Studies in Kansas City

NCT06731478Recruiting

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

This clinical trial is designed to assess the efficacy and safety of the triplet combination of trastuzumab deruxtecan (ENHERTU, T-DXd, DS-8201a) plus a fluoropyrimidine plus pembrolizumab versus stan...

Kansas City, KSPHASE3726 participantsDaiichi Sankyo

View Study Details

NCT05880199Recruiting

BSGM to Evaluate Patients With GI Symptoms

The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with G...

Kansas City, KS685 participantsChildren's Hospital of Philadelphia

View Study Details

NCT07043400Recruiting

A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

This study is designed to assess the levels of drug exposure following treatment with tislelizumab administered as a subcutaneous (SC) injection compared to intravenous infusion (IV) as first-line the...

Kansas City, KSPHASE3351 participantsBeiGene

View Study Details

NCT05947071Recruiting

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

Influenza virus is a significant pathogen in pediatric solid organ transplant (SOT) recipients. However, these individuals respond poorly to standard-dose (SD) inactivated influenza vaccine (IIV). Rec...

Kansas City, KSPHASE2312 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT05570448Recruiting

Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)

This will be a randomized clinical trial examining the efficacy and safety of ARAT (intervention group) in patients with chronic GERD symptoms (typical symptoms of GERD, i.e. heartburn or acid reflux/...

Kansas City, KSNA36 participantsMidwest Veterans' Biomedical Research Foundation

View Study Details

About Geographic Atrophy Clinical Trials in Kansas City

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 5 geographic atrophy clinical trials recruiting participants in Kansas City, KS. These studies are seeking a combined 2,110 participants. Research is being sponsored by Daiichi Sankyo, Children's Hospital of Philadelphia, BeiGene and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Kansas City — FAQ

Are there geographic atrophy clinical trials in Kansas City?

Yes, there are 5 geographic atrophy clinical trials currently recruiting in Kansas City, KS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 5 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated July 17, 2026 from ClinicalTrials.gov